Gut microbiome in patients with early-stage and late-stage endometriosis

From BugSigDB
Reviewed Marked as Reviewed by KateRasheed on 2025-4-29
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI Uniform resource identifier for web resources.
Authors
Cai Z, Zhou Z, Huang S, Ma S, Chen Y, Cao Y, Ma Y
Journal
BMC women's health
Year
2025
Keywords:
Dysmenorrhea, Endometriosis, Gut microbiota
BACKGROUND: Endometriosis is a chronic inflammatory gynecological disease. Previous studies have explored relationships between endometriosis and the microbiota, but none have focused on differences in gut microbiota between early-stage and late-stage endometriosis patients or their connections to dysmenorrhea symptoms. This study compared gut microbiota compositions between early-stage and late-stage endometriosis patients using amplicon sequencing and further analyzed their dysmenorrhea symptoms. METHODS: To minimize seasonal and dietary impacts, we recruited Guangdong residents hospitalized for surgery at Zhujiang Hospital. Participants underwent preoperative screening based on enrollment criteria and fecal samples were collected. Endometriosis was classified according to the American Society for Reproductive Medicine (ASRM) staging system based on surgincal and pathological findings. Stage I-II cases were designated as early-stage endometriosis, and Stage III-IV as late-stage endometriosis. RESULTS: A total of 112 patient fecal samples were collected, with 75 (median age, 32 years [range, 18-49 years]) meeting the enrollment criteria, including 39 early-stage (32 Stage I and 7 Stage II) and 36 late-stage (16 Stage III and 20 Stage IV) patients. The gut microbiota structure and functions in early-stage patients significantly differed from those in late-stage cases. Dysmenorrhea was associated with specific microbial traits. Late-stage patients with dysmenorrhea displayed distinctly different gut profiles compared to other endometriosis groups. Bartonella, Snodgrassella, and other taxa were enriched in late-stage cases, while Bacteroides, and Prevotella were decreased. CONCLUSION: The gut microbial community structure in early-stage endometriosis patients significantly differs from that in late-stage cases, with late-stage patients experiencing dysmenorrhea displaying particularly distinct gut profiles. Predicted functional analysis indicated suppressed steroid biosynthesis pathways in the gut of late-stage endometriosis patients. In conclusion, it is plausible that the multiple effects of steroids on the lower gastrointestinal tract may involve microbiota alterations, suggesting the need for further investigations.

Experiment 2


Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/13

Curator: Joiejoie

Revision editor(s): Joiejoie

Differences from previous experiment shown

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Endometriosis endometriosis,Endometriosis (clinical),endometriosis (disease),Endometriosis (disorder),Endometriosis (morphologic abnormality),ENDOMETRIOSIS NEC,Endometriosis NOS,Endometriosis NOS (disorder),Endometriosis of other specified sites,Endometriosis, site unspecified,Endometriosis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Early-stage Endometriosis (Stage I-II)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Late-stage Endometriosis (Stage III-IV)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients diagnosed with late-stage endometriosis (Stage III and Stage IV) according to the revised American Society for Reproductive Medicine (r-ASRM) classification system, confirmed by surgical and pathological examination.
Group 0 sample size Number of subjects in the control (unexposed) group
39
Group 1 sample size Number of subjects in the case (exposed) group
36
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
6 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
T-Test
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/14

Curator: Joiejoie

Revision editor(s): Joiejoie, KateRasheed

Source: Fig. 2D & Fig. S1A

Description: Differential microbes between the early- and late-stage endometriosis groups.

Abundance in Group 1: increased abundance in Late-stage Endometriosis (Stage III-IV)

NCBI Quality ControlLinks
Arthrobacter
Bacteroides
Bacteroides cellulosilyticus
Bacteroides uniformis
Bartonella
Blautia
Bombella
Commensalibacter
Enterococcus
Enterococcus cecorum
Frischella
Gilliamella
Intestinimonas
Intestinimonas butyriciproducens
Lactobacillus
Lactobacillus apis
Oxalobacter
Oxalobacter formigenes
Shuttleworthella
Snodgrassella
Tannerellaceae
metagenome
uncultured Gammaproteobacteria bacterium
uncultured Oscillospiraceae bacterium
uncultured bacterium
uncultured organism
Lachnospiraceae_UCG-010Lachnospiraceae_UCG-010
UCG-002UCG-002
UCG-005UCG-005
uncultured Hyphomicrobiales bacterium

Revision editor(s): Joiejoie, KateRasheed

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/14

Curator: Joiejoie

Revision editor(s): Joiejoie, KateRasheed

Source: Fig. 2D & Fig. S1A

Description: Differential microbes between the early- and late-stage endometriosis groups.

Abundance in Group 1: decreased abundance in Late-stage Endometriosis (Stage III-IV)

NCBI Quality ControlLinks
Bacteroides
Bacteroides caecimuris
Butyricicoccus
Candidatus Saccharimonas
Citrobacter
Gordonia
Herbaspirillum
Lactobacillus
Lactobacillus johnsonii
Lactococcus
Megamonas
Mycobacterium
Phascolarctobacterium
Phyllobacterium
Prevotella
Pseudolabrys
Ralstonia
Ruminococcaceae bacterium UCG-005
Ruminococcus
Ruminococcus flavefaciens
Saccharofermentans
[Eubacterium] siraeum
rumen bacterium NK4A214
uncultured bacterium
uncultured organism
uncultured rumen bacterium
Bacteroidales RF16 groupBacteroidales RF16 group
Rikenellaceae_RC9_gut_groupRikenellaceae_RC9_gut_group
Prevotellacea_UCG-001Prevotellacea_UCG-001
Ruminococcus sp.

Revision editor(s): Joiejoie, KateRasheed

Experiment 5


Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/13

Curator: Joiejoie

Revision editor(s): Joiejoie

Differences from previous experiment shown

Subjects

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Dysmenorrhea Painful menstruation,Dysmenorrhea,dysmenorrhea
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Early-Stage-F (patients without dysmenorrhea)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Early-Stage-T (patients with dysmenorrhea)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group consists of patients diagnosed with early-stage endometriosis (Stage I–II) who reported experiencing preoperative dysmenorrhea.
Group 0 sample size Number of subjects in the control (unexposed) group
23
Group 1 sample size Number of subjects in the case (exposed) group
16

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/14

Curator: Joiejoie

Revision editor(s): Joiejoie

Source: Fig. 4A

Description: Differential species between dysmenorrhea positive and negative subgroups within the early-stage endometriosis group

Abundance in Group 1: increased abundance in Early-Stage-T (patients with dysmenorrhea)

NCBI Quality ControlLinks
Lactococcus lactis
Rothia mucilaginosa
Ruminococcus flavefaciens
Ruoffia tabacinasalis
Streptococcus anginosus
unclassified Weissella
unclassified Coprococcus

Revision editor(s): Joiejoie

Experiment 6


Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/13

Curator: Joiejoie

Revision editor(s): Joiejoie

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Late-Stage-F (patients without dysmenorrhea)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Late-Stage-T (patients with dysmenorrhea)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group refers to patients diagnosed with late-stage endometriosis (Stage III–IV) who reported experiencing preoperative dysmenorrhea.
Group 0 sample size Number of subjects in the control (unexposed) group
19
Group 1 sample size Number of subjects in the case (exposed) group
17

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/14

Curator: Joiejoie

Revision editor(s): Joiejoie

Source: Fig. 4A

Description: Differential species between dysmenorrhea-positive and negative subgroups within the late-stage endometriosis group.

Abundance in Group 1: increased abundance in Late-Stage-T (patients with dysmenorrhea)

NCBI Quality ControlLinks
Bacteroides intestinalis
Bacteroides uniformis
Cloacibacillus evryensis
Clostridium perfringens
Herbaspirillum
Odoribacter splanchnicus
Parabacteroides gordonii
uncultured Odoribacter sp.
uncultured rumen bacterium
Hafnia.ObesumbacteriumHafnia.Obesumbacterium
uncultured Lachnospiraceae bacterium
Lachnospiraceae UCG-010Lachnospiraceae UCG-010

Revision editor(s): Joiejoie

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/14

Curator: Joiejoie

Revision editor(s): Joiejoie

Source: Fig. 4A

Description: Differential species between dysmenorrhea-positive and negative subgroups within the late-stage endometriosis group.

Abundance in Group 1: decreased abundance in Late-Stage-T (patients with dysmenorrhea)

NCBI Quality ControlLinks
Lactobacillales

Revision editor(s): Joiejoie

Experiment 7


Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/13

Curator: Joiejoie

Revision editor(s): Joiejoie

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Early-stage-T
Group 1 name Corresponds to the case (exposed) group for case-control studies
Late-stage-T
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group refers to patients with dysmenorrhea diagnosed with late-stage endometriosis, as analyzed for gut microbiota composition.
Group 0 sample size Number of subjects in the control (unexposed) group
16

Lab analysis

Statistical Analysis

Statistical test
ANOVA


Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/15

Curator: Joiejoie

Revision editor(s): Joiejoie, KateRasheed

Source: Fig. 6D

Description: Relative abundance levels of 10 differential species consistently enriched between early-stage and late-stage groups.

Abundance in Group 1: increased abundance in Late-stage-T

NCBI Quality ControlLinks
Bombella
Commensalibacter
Snodgrassella
uncultured Hyphomicrobiales bacterium

Revision editor(s): Joiejoie, KateRasheed

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/25

Curator: Joiejoie

Revision editor(s): Joiejoie, KateRasheed

Source: Fig. 6D

Description: Relative abundance levels of 10 differential species consistently enriched between early-stage and late-stage groups.

Abundance in Group 1: decreased abundance in Late-stage-T

NCBI Quality ControlLinks
Bacteroides caecimuris
Xylanibacter ruminicola
Bacteroidales RF16 groupBacteroidales RF16 group
uncultured rumen bacterium

Revision editor(s): Joiejoie, KateRasheed

Experiment 8


Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/13

Curator: Joiejoie

Revision editor(s): Joiejoie

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Early-stage-F
Group 1 name Corresponds to the case (exposed) group for case-control studies
Late-stage-F
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group refers to patients without dysmenorrhea who are diagnosed with late-stage endometriosis, as examined for gut microbiota differences.
Group 0 sample size Number of subjects in the control (unexposed) group
23
Group 1 sample size Number of subjects in the case (exposed) group
19

Lab analysis

Statistical Analysis

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/15

Curator: Joiejoie

Revision editor(s): Joiejoie, KateRasheed

Source: Fig. 6D

Description: Relative abundance levels of 10 differential species consistently enriched between early-stage and late-stage groups.

Abundance in Group 1: increased abundance in Late-stage-F

NCBI Quality ControlLinks
Bombella
Commensalibacter
Snodgrassella
uncultured Hyphomicrobiales bacterium

Revision editor(s): Joiejoie, KateRasheed

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-4-29

Curated date: 2025/04/25

Curator: Joiejoie

Revision editor(s): Joiejoie, KateRasheed

Source: Fig. 6D

Description: Relative abundance levels of 10 differential species consistently enriched between early-stage and late-stage groups

Abundance in Group 1: decreased abundance in Late-stage-F

NCBI Quality ControlLinks
Bacteroides caecimuris
Xylanibacter ruminicola
Bacteroidales RF16 groupBacteroidales RF16 group
uncultured rumen bacterium

Revision editor(s): Joiejoie, KateRasheed